Johnson & Johnson (NYSE:JNJ) Q3 2023 Earnings Call Transcript

Johnson & Johnson (NYSE:JNJ) Q3 2023 Earnings Call Transcript October 17, 2023 Operator: Good morning, and welcome to Johnson & Johnson’s Third Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being recorded. If anyone has any objections, you may disconnect […]

Related Keywords

China ,New Jersey ,United States ,Belgium ,San Diego ,California ,Netherlands ,Russia ,Anipo ,Guangdong ,Switzerland ,America ,Matt Miksic ,Josh Jennings ,Louise Chen ,Joaquin Duato ,Erik Haas ,Jessica Moore ,Joanne Wuensch ,Joe Wolk ,Danielle Antalffy ,Geoff Meacham ,Terence Flynn ,Larry Biegelsen ,John Reed ,Chris Schott ,Ahmet Tezel ,David Risinger ,Chris Shibutani ,New York Stock Exchange ,Johnson ,Novartis ,European Commission ,Supreme Court ,Abiomed ,Jersey Bankruptcy Court ,Cellular Biomedicine Group ,Cantor Fitzgerald ,Wells Fargo ,Citibank ,Astrazeneca ,Morgan Stanley ,European Union ,European Society Of Medical Oncology ,York Stock Exchange ,Interventional Solutions ,Barclays ,District Court ,Kenvue Inc ,Goldman Sachs ,Innovative Medicine ,Worldwide Medtech ,Kenvue Debt Offering ,Inflation Reduction ,Presidential Symposium ,European Society ,Medical Oncology ,American College ,Rheumatology Annual Meeting ,Abiomed Impella ,Myasthenia Gravis ,For Medtech ,Enterprise Business Review ,New York Stock ,Employers Look ,New Jersey Bankruptcy Court ,Federal District Court ,Innovative Medicines ,Vamil Divan ,Analyst Day ,Ottava Day ,Investor Relations ,Ohnson Johnson ,Sales Growth ,Perator Instructions ,